AGL

AGL

USD

agilon health inc. Common Stock

$3.900-0.090 (-2.256%)

Цена в режиме реального времени

Healthcare
Medical Care Facilities
Соединенные Штаты

График цен

Ключевые показатели

Рыночные показатели
Фундаментальные показатели компании
Статистические данные торговли

Рыночные показатели

Открытие

$3.990

Максимум

$3.995

Минимум

$3.785

Объем

0.01M

Фундаментальные показатели компании

Рыночная капитализация

1.6B

Отрасль

Medical Care Facilities

Страна

United States

Статистические данные торговли

Средний объем

6.10M

Биржа

NYQ

Валюта

USD

52-недельный диапазон

Минимум $1.5Текущая $3.900Максимум $7.73

Отчет об анализе ИИ

Последнее обновление: 16 апр. 2025 г.
Сгенерировано ИИИсточник данных: Yahoo Finance, Bloomberg, SEC

[AGL: agilon health inc. Common Stock]: Mixed Analyst Views, Recent Price Jump - What's Next?

Stock Symbol: AGL Generate Date: 2025-04-16 02:30:17

Alright, let's take a look at agilon health (AGL). This healthcare company has been making some moves, and analysts are all over the place with their opinions, which can be confusing if you're just trying to figure out what's going on. So, let's break it down simply.

Recent News Buzz - What's the Vibe?

The news is a bit of a mixed bag, honestly. We've got analysts from different firms weighing in, and they're not all singing the same tune.

  • Some are getting more optimistic: Bernstein actually upgraded the stock to "Outperform" and bumped their price target way up to $8.50. That's a pretty strong positive signal. TD Cowen also raised their price target, though they're still just saying "Hold" for now.
  • Others are a bit more cautious: Baird, for example, kept their "Neutral" rating and lowered their price target. This suggests they're not seeing huge upside right now.

What does this mean? Basically, Wall Street is a bit divided on AGL. Some think it's got more room to run, while others are playing it cool. The fact that Bernstein is so bullish is definitely something to notice, though. It's also worth noting that the company is going to be at a big healthcare conference soon and will be reporting earnings. These events can often move the stock price.

Price Check - What's the Stock Been Doing?

Looking at the price chart over the last month or so, it's been a bit of a rollercoaster, but with a recent big jump.

  • Early March Slump: The stock was actually trending downwards for a while in early March, hitting lows around $2.80-$3.00.
  • Then, a Turnaround: Starting mid-March, things started to pick up. The price climbed pretty steadily through March.
  • Big Pop!: Then, BAM! On April 8th, the stock price skyrocketed from around $4 to over $5. It jumped on really heavy trading volume, meaning a lot of people were buying. Since then, it's been hanging around the $5.50-$5.75 range.

Where are we now? The stock is currently around $5.60 (previous close). That big jump on April 8th is hard to ignore. It suggests something shifted investor sentiment, maybe related to that Bernstein upgrade or just general market vibes.

AI Prediction in the Mix: Interestingly, the AI prediction model thinks the price is going to inch up a bit more over the next few days, but only by small percentages (around 1-3% per day). It's not predicting another huge jump right away.

Outlook & Ideas - What Could Happen Next?

Putting it all together, here's a possible way to look at AGL right now:

  • Near-Term Lean: The recent price jump and the Bernstein upgrade suggest there might be some bullish momentum in the short term. The AI predictions, while modest, also point to continued upward movement.
  • Potential 'Buy' Consideration? If you were thinking about getting into AGL, the current price area around $5.50 - $5.70 might be an interesting spot to consider. Why? Because it's right around where the stock has been consolidating after that big jump. It could be a sign of a new, higher base forming. However, and this is important, the stock has already moved up a lot recently, so some caution is definitely warranted.
  • Entry Level Idea: Maybe watch for a slight dip towards the $5.50 level. If it holds around there, that could be a potential entry point. But again, no guarantees!
  • Exit/Stop-Loss Thoughts:
    • Profit Target: If Bernstein's $8.50 target is in the back of your mind, that's a potential longer-term profit area. For a shorter-term trade, maybe look closer to the other analyst targets around $6.00.
    • Stop-Loss: To manage risk, a stop-loss could be placed below the recent lows, perhaps around $5.05. This is just below some recent price action and could help limit losses if the stock reverses.

Important Caveat: This is just based on the limited information we have here. The analyst opinions are mixed, and the AI prediction is just one model's view. The stock market is unpredictable, and AGL is no exception.

Company Context - Quick Background

Just a quick reminder: agilon health is in the business of providing healthcare services for seniors. They work with primary care doctors. The healthcare sector itself can be sensitive to news about regulations, costs, and overall economic conditions. Keep that in mind as you follow AGL.

In short: AGL has seen a recent price surge and has some positive analyst attention, but also some caution. It's a stock that's showing some potential, but like any investment, it comes with risks. Keep an eye on upcoming news and earnings reports to get a clearer picture.


Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Investing in the stock market involves risk, and you could lose money. Always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Связанные новости

Analyst Upgrades

JMP Securities Reiterates Market Perform on Agilon Healthto Market Perform

JMP Securities analyst Constantine Davides reiterates Agilon Health from Market Perform to Market Perform.

Просмотреть больше
JMP Securities Reiterates Market Perform on Agilon Healthto Market Perform
Analyst Upgrades

Citigroup Upgrades Agilon Health to Buy, Raises Price Target to $5

Citigroup analyst Daniel Grosslight upgrades Agilon Health from Neutral to Buy and raises the price target from $3.25 to $5.

Просмотреть больше
Citigroup Upgrades Agilon Health to Buy, Raises Price Target to $5
Analyst Upgrades

TD Cowen Maintains Hold on Agilon Health, Raises Price Target to $6

TD Cowen analyst Ryan Langston maintains Agilon Health with a Hold and raises the price target from $3.5 to $6.

Просмотреть больше
TD Cowen Maintains Hold on Agilon Health, Raises Price Target to $6
Analyst Upgrades

Baird Maintains Neutral on Agilon Health, Lowers Price Target to $5

Baird analyst Michael Halloran maintains Agilon Health with a Neutral and lowers the price target from $6 to $5.

Просмотреть больше
Baird Maintains Neutral on Agilon Health, Lowers Price Target to $5
Analyst Upgrades

Bernstein Upgrades Agilon Health to Outperform, Raises Price Target to $8.5

Bernstein analyst Amir Farahan upgrades Agilon Health from Market Perform to Outperform and raises the price target from $3.3 to $8.5.

Просмотреть больше
Bernstein Upgrades Agilon Health to Outperform, Raises Price Target to $8.5

Прогноз ИИBeta

Рекомендация ИИ

Бычий

Обновлено в: 28 апр. 2025 г., 14:27

МедвежийНейтральныйБычий

69.4% Уверенность

Риск и торговля

Уровень риска3/5
Средний риск
Подходит для
СтоимостьРост
Руководство по торговле

Точка входа

$3.90

Взять прибыль

$3.96

Остановить убытки

$3.49

Ключевые факторы

DMI показывает медвежий тренд (ADX:17.9, +DI:6.9, -DI:7.7), что предполагает осторожность
Текущая цена очень близка к уровню поддержки ($3.88), что предполагает сильную возможность покупки
Объем торгов в 4.8 раз превышает среднее значение (72,020), что указывает на чрезвычайно сильное покупательское давление
MACD 0.0062 ниже сигнальной линии 0.0102, что указывает на медвежье пересечение

Оставаться в курсе

Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.